Neurobiology of Disease

Article	Citations
The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier	336
Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis	116
How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synucle	107
Long-lasting blood-brain barrier dysfunction and neuroinflammation after traumatic brain injury	106
Neuropathological evidence of body-first vs. brain-first Lewy body disease	102
Microglia reprogram metabolic profiles for phenotype and function changes in central nervous system	99
Plasmalogens, platelet-activating factor and beyond – Ether lipids in signaling and neurodegeneration	82
Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease	81
Oligomeric α-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson's disease	74
INPP5D expression is associated with risk for Alzheimer's disease and induced by plaque-associated microglia	73
Clinical and imaging evidence of brain-first and body-first Parkinson's disease	69
Obstructive Sleep Apnea and Its Treatment in Aging: Effects on Alzheimer’s disease Biomarkers, Cognition, Brain Structure and Neurophysiology	68
Local field potentials in Parkinson's disease: A frequency-based review	67
Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons	65
Co-expression patterns of microglia markers Iba1, TMEM119 and P2RY12 in Alzheimer's disease	64
Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response	63
An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington's disease	62
Cilia, ciliopathies and hedgehog-related forebrain developmental disorders	62
Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer's disease	60
Primary cilia and ciliary signaling pathways in aging and age-related brain disorders	60
Schwann cell functions in peripheral nerve development and repair	60
Soluble TREM2: Innocent bystander or active player in neurological diseases?	59
TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia	58
The genetic architecture of ALS	57
Primary motor cortex in Parkinson’s disease: Functional changes and opportunities for neurostimulation	57

Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across neurodegeneration	55
Beta-adrenergic receptor antagonism is proinflammatory and exacerbates neuroinflammation in a mouse model of Alzheimer's Disease	55
Roles of lysosomotropic agents on LRRK2 activation and Rab10 phosphorylation	55
Mechanosensation in traumatic brain injury	52
SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein	51
Indoles as essential mediators in the gut-brain axis. Their role in Alzheimer's disease	50
Pleiotropic effects of BDNF on the cerebellum and hippocampus: Implications for neurodevelopmental disorders	50
Animal models of brain-first and body-first Parkinson's disease	46
Molecular chaperones and Parkinson's disease	45
Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia	45
Small RNA modifications in Alzheimer's disease	45
The association of epigenetic clocks in brain tissue with brain pathologies and common aging phenotypes	45
PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats	45
What are activated and reactive glia and what is their role in neurodegeneration?	44
Neuron-astrocyte transmitophagy is altered in Alzheimer's disease	42
Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments	41
Brain edema formation and therapy after intracerebral hemorrhage	41
Immune responses in the Parkinson's disease brain	40
Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer's disease	40
The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease	39
Characterization of tau binding by gosuranemab	39
Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo	39
The role of Alzheimer's disease risk genes in endolysosomal pathways	39
(R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: A role of gut–microbiota–brain axis	39
Modeling chemotherapy induced neurotoxicity with human induced pluripotent stem cell (iPSC) -derived sensory neurons	39
Glucocorticoid impairs mitochondrial quality control in neurons	39
Analysis of homozygous and heterozygous Csf1r knockout in the rat as a model for understanding microglial function in brain development and the impacts of human CSF1R mutations	38
Striatal synaptic adaptations in Parkinson's disease	38
Cerebral small vessel disease alters neurovascular unit regulation of microcirculation integrity involved in vascular cognitive impairment	38
PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia	38
Amyloid beta acts synergistically as a pro-inflammatory cytokine	38
The three-phase enriched environment paradigm promotes neurovascular restorative and prevents learning impairment after ischemic stroke in rats	36
Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease	36
Advances in protein-protein interaction network analysis for Parkinson's disease	36
Genuine high-order interactions in brain networks and neurodegeneration	36
Glial-neuron crosstalk in health and disease: A focus on metabolism, obesity, and cognitive impairment	35
Inflammation in dementia with Lewy bodies	35
The epitranscriptome in stem cell biology and neural development	35
RNA-mediated toxicity in C9orf72 ALS and FTD	35
Developmental alterations in firing properties of hippocampal CA1 inhibitory and excitatory neurons in a mouse model of Dravet syndrome	35
Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders	34
Traumatic brain injury in women across lifespan	32
Expansion microscopy: A powerful nanoscale imaging tool for neuroscientists	32
Regulation of neuronal autophagy and the implications in neurodegenerative diseases	32
Extracellular vesicles in the treatment of neurological disorders	32
Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis	31
Robust chronic convulsive seizures, high frequency oscillations, and human seizure onset patterns in an intrahippocampal kainic acid model in mice	31
Subthalamic deep brain stimulation induces finely-tuned gamma oscillations in the absence of levodopa	31
ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's disease	31
Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine	31

Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage	30
Super-resolution STED microscopy in live brain tissue	30
Leptin enhances adult neurogenesis and reduces pathological features in a transgenic mouse model of Alzheimer’s disease	30
APOE4 confers transcriptomic and functional alterations to primary mouse microglia	30
Striatal glutamatergic hyperactivity in Parkinson's disease	29
Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome	29
Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis	29
Behavioral, axonal, and proteomic alterations following repeated mild traumatic brain injury: Novel insights using a clinically relevant rat model	28
Directing LRRK2 to membranes of the endolysosomal pathway triggers RAB phosphorylation and JIP4 recruitment	28
Upregulated hexokinase 2 expression induces the apoptosis of dopaminergic neurons by promoting lactate production in Parkinson's disease	28
Vitamin E prevents lipid peroxidation and iron accumulation in PLA2G6-Associated Neurodegeneration	27
Deep brain stimulation of thalamus for epilepsy	27
Molecular mechanisms of psychiatric diseases	27
Synaptic pathology in Huntington's disease: Beyond the corticostriatal pathway	27
Therapeutic targeting of STING-TBK1-IRF3 signalling ameliorates chronic stress induced depression-like behaviours by modulating neuroinflammation and microglia phagocytosis	27
Near-infrared nanoscopy with carbon-based nanoparticles for the exploration of the brain extracellular space	27
Epigenetic principles underlying epileptogenesis and epilepsy syndromes	27
Neuroimaging findings related to glymphatic system alterations in older adults with metabolic syndrome	26
Abnormal patterns of sleep and EEG power distribution during non-rapid eye movement sleep in the sheep model of Huntington's disease	26
Monitoring α-synuclein aggregation	26
TFEB in Alzheimer's disease: From molecular mechanisms to therapeutic implications	25
Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms	25
Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice	25
Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis	25
Understanding the contributions of VPS35 and the retromer in neurodegenerative disease	25
Delayed administration of high dose human immunoglobulin G enhances recovery after traumatic cervical spinal cord injury by modulation of neuroinflammation and protection of the blood spinal cord barr	25
Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression	25
STED and parallelized RESOLFT optical nanoscopy of the tubular endoplasmic reticulum and its mitochondrial contacts in neuronal cells	25
Dopamine depletion can be predicted by the aperiodic component of subthalamic local field potentials	25
Gallic acid attenuates blood-spinal cord barrier disruption by inhibiting Jmjd3 expression and activation after spinal cord injury	25
Impact of intestinal disorders on central and peripheral nervous system diseases	25
AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP/PS1 mice	25
Striatal Synaptic Dysfunction in Dystonia and Levodopa-Induced Dyskinesia	25
MANF is neuroprotective against ethanol-induced neurodegeneration through ameliorating ER stress	24
TRPM2 contributes to neuroinflammation and cognitive deficits in a cuprizone-induced multiple sclerosis model via NLRP3 inflammasome	24
Neuroinflammation microenvironment sharpens seizure circuit	24
NADPH oxidase 2 activity in Parkinson's disease	24
Exosomes as a potential messenger unit during heterochronic parabiosis for amelioration of Huntington's disease	24
Epigenetic regulators of neuronal ferroptosis identify novel therapeutics for neurological diseases: HDACs, transglutaminases, and HIF prolyl hydroxylases	24
Dopaminergic modulation of primary motor cortex: From cellular and synaptic mechanisms underlying motor learning to cognitive symptoms in Parkinson’s disease	24
Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease	24
Eight cylindrical contact lead recordings in the subthalamic region localize beta oscillations source to the dorsal STN	24
Decoding the neurocircuitry of gut feelings: Region-specific microbiome-mediated brain alterations	24
X-linked cellular mosaicism underlies age-dependent occurrence of seizure-like events in mouse models of CDKL5 deficiency disorder	24
Mechanisms of disease-modifying effect of saracatinib (AZD0530), a Src/Fyn tyrosine kinase inhibitor, in the rat kainate model of temporal lobe epilepsy	24
Muscle fiber-type specific terminal Schwann cell pathology leads to sprouting deficits following partial denervation in SOD1G93A mice	24
Suppression of glycogen synthesis as a treatment for Lafora disease: Establishing the window of opportunity	23
To target Tau pathologies, we must embrace and reconstruct their complexities	23
Type I interferon response-related microglial Mef2c deregulation at the onset of Alzheimer's pathology in 5×FAD mice	23
Nanoparticle encapsulated oxytocin increases resistance to induced seizures and restores social behavior in Scn1a-derived epilepsy	23
TREM2 modulates neuroinflammation with elevated IRAK3 expression and plays a neuroprotective role after experimental SAH in rats	23
Astrocyte-neuron circuits in epilepsy	23
Small nucleolar RNAs in plasma extracellular vesicles and their discriminatory power as diagnostic biomarkers of Alzheimer's disease	23
Blood brain barrier and inflammation in depression	23
Quantifying cerebrospinal fluid dynamics: A review of human neuroimaging contributions to CSF physiology and neurodegenerative disease	23
MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia	23
Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons	23
Role of LGI1 protein in synaptic transmission: From physiology to pathology	23
Gut dysbiosis and age-related neurological diseases in females	22
Detrimental impacts of mixed-ion radiation on nervous system function	22
Exposure to anti-seizure medications impact growth of gut bacterial species and subsequent host response	22
Dystonia 16 (DYT16) mutations in PACT cause dysregulated PKR activation and eIF2α signaling leading to a compromised stress response	22
Inflammatory and neurodegenerative pathophysiology implicated in postpartum depression	22
Spatial and temporal profile of high-frequency oscillations in posttraumatic epileptogenesis	22
Striatal circuit development and its alterations in Huntington's disease	22
Role of PACAP in migraine: An alternative to CGRP?	22
Ethanol-mediated alterations in oligodendrocyte differentiation in the developing brain	22
Ischemic brain edema: Emerging cellular mechanisms and therapeutic approaches	22
Neuroprotective effects of a dendrimer-based glutamate carboxypeptidase inhibitor on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic brain injury	22
Gait variability is linked to the atrophy of the Nucleus Basalis of Meynert and is resistant to STN DBS in Parkinson's disease	22
Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status	22
Multi-omic insights into Parkinson's Disease: From genetic associations to functional mechanisms	22
Melatonin treatment of repetitive behavioral deficits in the Cntnap2 mouse model of autism spectrum disorder	22
Key role of the gut–microbiota–brain axis via the subdiaphragmatic vagus nerve in demyelination of the cuprizone-treated mouse brain	22
Epileptic-network-based prediction and control of seizures in humans	21
DNA damage and repair following traumatic brain injury	21
Small molecule modulation of TrkB and TrkC neurotrophin receptors prevents cholinergic neuron atrophy in an Alzheimer's disease mouse model at an advanced pathological stage	21
Gut microbiome effects on neuronal excitability & activity: Implications for epilepsy	21
The gut microbiota as a biomarker in epilepsy	21
Neurological sequela and disruption of neuron-glia homeostasis in SARS-CoV-2 infection	21

Parkinson's disease risk genes act in glia to control neuronal α-synuclein toxicity	21
Increased ATP release and CD73-mediated adenosine A2A receptor activation mediate convulsion-associated neuronal damage and hippocampal dysfunction	21
Overlaps, gaps, and complexities of mouse models of Developmental and Epileptic Encephalopathy	21
Elezanumab, a human anti-RGMa monoclonal antibody, promotes neuroprotection, neuroplasticity, and neurorecovery following a thoracic hemicompression spinal cord injury in non-human primates	21
How does neurovascular unit dysfunction contribute to multiple sclerosis?	21
Postsynaptic autism spectrum disorder genes and synaptic dysfunction	21
Proteomic signature of the Dravet syndrome in the genetic Scn1a-A1783V mouse model	21
Synaptic changes induced by cannabinoid drugs and cannabis use disorder	21
Role of gut microbiota in neuropathy and neuropathic pain states: A systematic preclinical review	21
Bacterial sepsis increases hippocampal fibrillar amyloid plaque load and neuroinflammation in a mouse model of Alzheimer's disease	21
VPS35 and the mitochondria: Connecting the dots in Parkinson's disease pathophysiology	21
The silence of the fats: A MAM’s story about Alzheimer	21
Thioredoxin interacting protein regulates age-associated neuroinflammation	20
Local diffusion in the extracellular space of the brain	20
Role of lipocalin 2 in stroke	20
Early changes in synaptic and intrinsic properties of dentate gyrus granule cells in a mouse model of Alzheimer's disease neuropathology and atypical effects of the cholinergic antagonist atropine	20
Rethinking the cilia hypothesis of hydrocephalus	20
Epilepsy and neurobehavioral abnormalities in mice with a dominant-negative KCNB1 pathogenic variant	20
The effect of aquaporin-4 mis-localization on Aβ deposition in mice	20
DNAJB6 suppresses alpha-synuclein induced pathology in an animal model of Parkinson's disease	20
SUMOylation of spastin promotes the internalization of GluA1 and regulates dendritic spine morphology by targeting microtubule dynamics	20
Microglia in epilepsy	20
ALS-linked cytoplasmic FUS assemblies are compositionally different from physiological stress granules and sequester hnRNPA3, a novel modifier of FUS toxicity	20
Facemasks and face recognition: Potential impact on synaptic plasticity	20
Inclusion of African American/Black adults in a pilot brain proteomics study of Alzheimer's disease	20
Neuron-specific mitochondrial oxidative stress results in epilepsy, glucose dysregulation and a striking astrocyte response	20
Alternative platelet activation pathways and their role in neurodegenerative diseases	20
Alpha-synuclein pathology, microgliosis, and parvalbumin neuron loss in the amygdala associated with enhanced fear in the Thy1-aSyn model of Parkinson's disease	20
Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders	20
The evolution of dystonia-like movements in TOR1A rats after transient nerve injury is accompanied by dopaminergic dysregulation and abnormal oscillatory activity of a central motor network	20
DUSP4 appears to be a highly localized endogenous inhibitor of epileptic signaling in human neocortex	20
The association of enlarged perivascular space with microglia-related inflammation and Alzheimer's pathology in cognitively normal elderly	20
Neurogranin in Alzheimer's disease and ageing: A human post-mortem study	20
CXCL1-CXCR1/2 signaling is induced in human temporal lobe epilepsy and contributes to seizures in a murine model of acquired epilepsy	20
The putative role of neuroinflammation in the complex pathophysiology of migraine: From bench to bedside	20
Antibiotic cocktail-induced gut microbiota depletion in different stages could cause host cognitive impairment and emotional disorders in adulthood in different manners	19
High-fat diet alters stress behavior, inflammatory parameters and gut microbiota in Tg APP mice in a sex-specific manner	19
Parkinson's disease uncovers an underlying sensitivity of subthalamic nucleus neurons to beta-frequency cortical input in vivo	19
Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism	19
Dermal and cardiac autonomic fiber involvement in Parkinson's disease and multiple system atrophy	19
Prenatal sevoflurane exposure causes neuronal excitatory/inhibitory imbalance in the prefrontal cortex and neurofunctional abnormality in rats	19
KNa1.1 gain-of-function preferentially dampens excitability of murine parvalbumin-positive interneurons	19
GDNF signaling in subjects with minimal motor deficits and Parkinson's disease	19
Rescue of aberrant huntingtin palmitoylation ameliorates mutant huntingtin-induced toxicity	19
Environmental triggers of Parkinson's disease – Implications of the Braak and dual-hit hypotheses	19
Extracellular alpha-synuclein: Sensors, receptors, and responses	19
HuD regulates SOD1 expression during oxidative stress in differentiated neuroblastoma cells and sporadic ALS motor cortex	19
The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease	19
Neuroimaging and neuropathology studies of X-linked dystonia parkinsonism	19
Evidence for immune system alterations in peripheral biological fluids in Parkinson's disease	19
Myelin and non-myelin debris contribute to foamy macrophage formation after spinal cord injury	19
Sensorineural hearing loss may lead to dementia-related pathological changes in hippocampal neurons	19
Gene expression in the epileptic (EL) mouse hippocampus	19
Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo	18
Mitochondrial function and Aβ in Alzheimer's disease postmortem brain	18
mTOR pathway: Insights into an established pathway for brain mosaicism in epilepsy	18
CERKL, a retinal dystrophy gene, regulates mitochondrial function and dynamics in the mammalian retina	18
Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease	18
Sexually dimorphic patterns in electroencephalography power spectrum and autism-related behaviors in a rat model of fragile X syndrome	18
Heterozygous GBA D409V and ATP13a2 mutations do not exacerbate pathological α-synuclein spread in the prodromal preformed fibrils model in young mice	18
NaV1.1 haploinsufficiency impairs glutamatergic and GABAergic neuron function in the thalamus	18
Early decreases in cortical mid-gamma peaks coincide with the onset of motor deficits and precede exaggerated beta build-up in rat models for Parkinson's disease	18
Super-resolution imaging reveals extrastriatal synaptic dysfunction in presymptomatic Huntington disease mice	18
Synaptic genes and neurodevelopmental disorders: From molecular mechanisms to developmental strategies of behavioral testing	18
LAR inhibitory peptide promotes recovery of diaphragm function and multiple forms of respiratory neural circuit plasticity after cervical spinal cord injury	18
Epigenetic pathways and plasticity in brain tumors	18
In vivo aggregation of presynaptic alpha-synuclein is not influenced by its phosphorylation at serine-129	18
Immune-related biomarkers for Parkinson's disease	18
Second hit hypothesis in dystonia: Dysfunctional cross talk between neuroplasticity and environment?	18
CD47 blocking antibody accelerates hematoma clearance and alleviates hydrocephalus after experimental intraventricular hemorrhage	17
Deficiency of autism-related Scn2a gene in mice disrupts sleep patterns and circadian rhythms	17
A new role for matrix metalloproteinase-3 in the NGF metabolic pathway: Proteolysis of mature NGF and sex-specific differences in the continuum of Alzheimer's pathology	17
The neuroprotective effects of GPR55 against hippocampal neuroinflammation and impaired adult neurogenesis in CSDS mice	17
THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiency	17
P2Y1 receptor inhibition rescues impaired synaptic plasticity and astroglial Ca2+-dependent activity in the epileptic hippocampus	17
Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease	17
Nanoscale synapse organization and dysfunction in neurodevelopmental disorders	17
Optineurin defects cause TDP43-pathology with autophagic vacuolar formation	17
Bilateral optogenetic activation of inhibitory cells favors ictogenesis	17
The individuality paradigm: Automated longitudinal activity tracking of large cohorts of genetically identical mice in an enriched environment	17
Facilitation of GluN2C-containing NMDA receptors in the external globus pallidus increases firing of fast spiking neurons and improves motor function in a hemiparkinsonian mouse model	17
Glial cells in the driver seat of leukodystrophy pathogenesis	17
Sex differences in thrombosis as it affects acute ischemic stroke	17
Differential involvement of insulin receptor substrate (IRS)-1 and IRS-2 in brain insulin signaling is associated with the effects on amyloid pathology in a mouse model of Alzheimer's disease	16
Regulation of distinct caspase-8 functions in retinal ganglion cells and astroglia in experimental glaucoma	16
Preserved noradrenergic function in Parkinson's disease patients with rest tremor	16
The altered sensitivity of acute stress induced anxiety-related behaviors by modulating insular cortex-paraventricular thalamus-bed nucleus of the stria terminalis neural circuit	16
Specific activation of GluN1-N2B NMDA receptors underlies facilitation of cortical spreading depression in a genetic mouse model of migraine with reduced astrocytic glutamate clearance	16
Current understanding of the interactions between metal ions and Apolipoprotein E in Alzheimer’s disease	16
Hippocampal network hyperexcitability in young transgenic mice expressing human mutant alpha-synuclein	16
Epigenetic mechanisms underlying enhancer modulation of neuronal identity, neuronal activity and neurodegeneration	16
Dual SMN inducing therapies can rescue survival and motor unit function in symptomatic ∆7SMA mice	16
Dysregulated clock gene expression and abnormal diurnal regulation of hippocampal inhibitory transmission and spatial memory in amyloid precursor protein transgenic mice	16
The brain and behavioral correlates of motor-related analgesia (MRA)	16
Mitochondria and calcium defects correlate with axonal dysfunction in GDAP1-related Charcot-Marie-Tooth mouse model	16